FRANKFURT, Sept 16 (Reuters) - Bayer AG:
* Says Xarelto anticoagulant approved in Canada
* Says marketing of the drug in Canada to start immediately
* Says expects marketing authorisation for Xarelto across all European Union member states 'very soon'
((Frankfurt Newsroom; +49 69 7565 1272))
tf.TFN-Europe_newsdesk@thomson.com vs COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
* Says Xarelto anticoagulant approved in Canada
* Says marketing of the drug in Canada to start immediately
* Says expects marketing authorisation for Xarelto across all European Union member states 'very soon'
((Frankfurt Newsroom; +49 69 7565 1272))
tf.TFN-Europe_newsdesk@thomson.com vs COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
© 2008 AFX News
